• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测可切除非小细胞肺癌患者脑转移的列线图。

A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients.

作者信息

Zhang Fanrong, Zheng Weihui, Ying Lisha, Wu Junzhou, Wu Shaoyuan, Ma Shenglin, Su Dan

机构信息

Cancer Research Institute, Zhejiang Cancer Hospital and Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology of Zhejiang Province, Hangzhou, China.

School of Life Sciences, Jiangsu Normal University, Xuzhou, China.

出版信息

Ann Surg Oncol. 2016 Sep;23(9):3033-9. doi: 10.1245/s10434-016-5206-3. Epub 2016 Apr 18.

DOI:10.1245/s10434-016-5206-3
PMID:27090794
Abstract

PURPOSE

Brain metastasis is a major cause leading to the failure of treatment management for non-small cell lung cancer (NSCLC) patients. The goal of this study was to establish an effective nomogram for prediction of brain metastases of resected NSCLC patients.

METHODS

We retrospectively investigated 637 operable NSCLC patients who received treatment at Zhejiang Cancer Hospital, China. A Cox proportional hazards regression model was performed to identify significant risk factors, and a nomogram was developed for predicting 3- and 5-year brain metastases rates.

RESULTS

Multivariate analysis identified four independent risk factors: neuron-specific enolase, histological type, number of metastatic lymph nodes, and tumor grade, and a nomogram was developed based on these factors. The effectiveness of the nomogram was validated using an internal bootstrap resampling approach, showing that the nomogram exhibited a sufficient level of discrimination according to the C-index (0.74, 95 % confidence interval 0.67-0.82).

CONCLUSIONS

The nomogram developed in this study demonstrated its discrimination capability for predicting 3- and 5-year occurrence of brain metastases, and can be used to identify high-risk patients.

摘要

目的

脑转移是导致非小细胞肺癌(NSCLC)患者治疗失败的主要原因。本研究的目的是建立一个有效的列线图,用于预测接受手术切除的NSCLC患者发生脑转移的情况。

方法

我们回顾性调查了在中国浙江省肿瘤医院接受治疗的637例可手术切除的NSCLC患者。采用Cox比例风险回归模型确定显著的危险因素,并建立一个列线图来预测3年和5年脑转移率。

结果

多因素分析确定了四个独立的危险因素:神经元特异性烯醇化酶、组织学类型、转移淋巴结数量和肿瘤分级,并基于这些因素建立了列线图。采用内部自抽样重采样方法验证了列线图的有效性,结果显示,根据C指数(0.74,95%置信区间0.67 - 0.82),列线图具有足够的区分度。

结论

本研究建立的列线图显示了其预测3年和5年脑转移发生情况的区分能力,可用于识别高危患者。

相似文献

1
A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients.预测可切除非小细胞肺癌患者脑转移的列线图。
Ann Surg Oncol. 2016 Sep;23(9):3033-9. doi: 10.1245/s10434-016-5206-3. Epub 2016 Apr 18.
2
A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients.预测老年早期非小细胞肺癌患者手术后预后的列线图。
Int J Surg. 2017 Jun;42:11-16. doi: 10.1016/j.ijsu.2017.04.024. Epub 2017 Apr 17.
3
A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients.用于预测根治性切除的非小细胞肺癌患者首次复发为脑转移的列线图。
Lung Cancer. 2015 May;88(2):201-7. doi: 10.1016/j.lungcan.2015.02.006. Epub 2015 Feb 16.
4
A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.用于预测 IIIA-N2 期非小细胞肺癌手术后生存情况的列线图。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1784-1792.e3. doi: 10.1016/j.jtcvs.2017.11.098. Epub 2017 Dec 20.
5
Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.非小细胞肺癌颅内转移切除后的生存时间:新列线图的建立与验证。
BMC Cancer. 2017 Nov 21;17(1):774. doi: 10.1186/s12885-017-3763-x.
6
Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional Study.基于网络的Nomograms 模型的建立与验证:用于精准预测完全切除的非小细胞肺癌患者的特定部位复发的条件风险:一项多机构研究。
Chest. 2018 Sep;154(3):501-511. doi: 10.1016/j.chest.2018.04.040. Epub 2018 Jun 18.
7
Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer.建立并验证一个列线图模型预测可切除非小细胞肺癌患者的生存情况。
J Clin Oncol. 2015 Mar 10;33(8):861-9. doi: 10.1200/JCO.2014.56.6661. Epub 2015 Jan 26.
8
An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy.一种与炎症相关的列线图,用于预测肺叶切除术后非小细胞肺癌患者的生存情况。
BMC Cancer. 2018 Jun 26;18(1):692. doi: 10.1186/s12885-018-4513-4.
9
Prognostic Factors and Prediction of Survival for Patients with Brain Metastases of Lung Adenocarcinoma.肺腺癌脑转移患者的预后因素和生存预测。
J Nippon Med Sch. 2021 Sep 1;88(4):319-325. doi: 10.1272/jnms.JNMS.2021_88-410. Epub 2021 Jan 16.
10
Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.列线图预测手术切除的 I 期非小细胞肺癌患者的特定原因死亡率:竞争风险分析。
Clin Lung Cancer. 2018 Mar;19(2):e195-e203. doi: 10.1016/j.cllc.2017.10.016. Epub 2017 Oct 28.

引用本文的文献

1
A nomogram to predict development of brain metastasis in non-small cell lung cancer patients: a retrospective analysis using routinely available medical records.预测非小细胞肺癌患者脑转移发生的列线图:一项使用常规可用医疗记录的回顾性分析
Lancet Reg Health Am. 2025 Aug 29;50:101213. doi: 10.1016/j.lana.2025.101213. eCollection 2025 Oct.
2
Added value of abdominal CT after treatment of lung cancer.肺癌治疗后腹部CT的附加值。
Quant Imaging Med Surg. 2025 Aug 1;15(8):6787-6800. doi: 10.21037/qims-2025-142. Epub 2025 Jul 30.
3
Application of prediction model based on CT radiomics in prognosis of patients with non-small cell lung cancer.
基于CT影像组学的预测模型在非小细胞肺癌患者预后中的应用
BMC Cancer. 2025 Aug 6;25(1):1273. doi: 10.1186/s12885-025-14544-8.
4
Antiplatelet Therapy Mitigates Brain Metastasis Risk in Non-Small Cell Lung Cancer: Insights from a Comprehensive Retrospective Study.抗血小板治疗可降低非小细胞肺癌脑转移风险:一项全面回顾性研究的见解
Cancers (Basel). 2025 Jun 20;17(13):2059. doi: 10.3390/cancers17132059.
5
Risk factors and clinical risk stratification of distant metastasis in early-stage lung cancer in never smokers.从不吸烟者早期肺癌远处转移的危险因素及临床风险分层
World J Surg Oncol. 2025 Jun 18;23(1):238. doi: 10.1186/s12957-025-03892-1.
6
Efficacy and safety of immune checkpoint inhibitors for brain metastases of non-small cell lung cancer: a systematic review and network meta-analysis.免疫检查点抑制剂治疗非小细胞肺癌脑转移的疗效和安全性:一项系统评价和网状Meta分析
Front Oncol. 2025 Apr 16;15:1513774. doi: 10.3389/fonc.2025.1513774. eCollection 2025.
7
MoLPre: A Machine Learning Model to Predict Metastasis of cT1 Solid Lung Cancer.MoLPre:一种预测cT1期实性肺癌转移的机器学习模型。
Clin Transl Sci. 2025 Apr;18(4):e70186. doi: 10.1111/cts.70186.
8
A clinical model to predict brain metastases in resected early-stage non-small cell lung cancer.一种预测切除的早期非小细胞肺癌脑转移的临床模型。
BMC Cancer. 2025 Feb 11;25(1):236. doi: 10.1186/s12885-025-13609-y.
9
Application of random survival forest to establish a nomogram combining clinlabomics-score and clinical data for predicting brain metastasis in primary lung cancer.应用随机生存森林构建列线图,结合临床实验室组学评分和临床数据预测原发性肺癌脑转移。
Clin Transl Oncol. 2025 Apr;27(4):1472-1483. doi: 10.1007/s12094-024-03688-x. Epub 2024 Sep 3.
10
Clinicopathological characteristics and prognosis of synchronous brain metastases from non-small cell lung cancer compared with metachronous brain metastases.非小细胞肺癌同时性脑转移与异时性脑转移的临床病理特征及预后比较
Front Oncol. 2024 May 22;14:1400792. doi: 10.3389/fonc.2024.1400792. eCollection 2024.